S1 Episode 4: Myelofibrosis: Considering TP53 and Post-MPN AML
Join Drs Tania Jain and Raajit Rampal as they discuss TP53, post-MPN AML, and high-risk MPNs in the context of myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape ...
5 Syys 202421min
S1 Episode 3: What's Your Approach? Treating Myelofibrosis
Join Drs Tania Jain and Lindsay Rein as they discuss the current treatment landscape and their approach to treating patients with myelofibrosis. Relevant disclosures can be found with the episode show...
7 Elo 202422min
S1 Episode 2: What's Next? Promising Trials and Therapeutics in Myelofibrosis
Join Drs Tania Jain and Aaron Gerds as they discuss the latest developments in clinical trials and investigational therapeutics for MPNs. Relevant disclosures can be found with the episode show notes ...
3 Heinä 202425min
S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use?
Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the risk stratification of myelofibrosis and the latest research in prefibrotic myelofibrosis. Relevant disclosures can b...
3 Heinä 202426min
